About Electrophysiology Devices
Cardiovascular diseases (CVDs) are associated with high mortality rate all over the world. Strokes and heart attacks are two major types of CVD contributing to the growing mortality rate globally. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease (CHD) is the most common type of CVD resulting in heart attack in the US. In the US, about 370,000 people die due to CHD every year. The EP diagnostics and treatment devices such as ablation catheters, pacemakers, and implantable cardioverter defibrillators (ICDs) are used extensively for the CVD treatment.
Technavio’s analysts forecast the global electrophysiology devices market to grow at a CAGR of 7.91% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global electrophysiology devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of electrophysiology devices.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Electrophysiology Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• GE Healthcare
• Medtronic
• Philips Healthcare
• St. Jude Medical
Other prominent vendors
• Siemens Healthcare
• LivaNova
• AngioDynamics
• Atrium Medical
• Biosense Webster
• Cook Group
• Edward Lifesciences
• Innovative Cardiovascular Solutions
• Transverse Medical
• Cardiac Science
• MicroPortScientific
• Welch Allyn
• Vimecon
• Suzuken
• Spacelabs Healthcare
• Cardiac Science
• Imricor Medical Systems
• Advanced Cardiac Therapeutics
• BIOTRONIK
Market driver
• Increasing incidence of arrhythmia cases
• For a full, detailed list, view our report
Market challenge
• Complications associated with ablation procedures
• For a full, detailed list, view our report
Market trend
• Use of mobile ECG monitoring systems
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Diagnostic EP devices
• Treatment EP devices
PART 07: Market segmentation by end-users
• Hospitals
• Clinics
• Diagnostic centers
PART 08: Geographical segmentation
• EP devices market in Americas
• EP devices market in EMEA
• EP devices market in APAC
PART 09: Market drivers
• Increasing incidence of arrhythmia cases
• Increasing preference for remote monitoring devices
• High demand for EP devices
PART 10: Impact of drivers
PART 11: Market challenges
• High cost of ablation procedures
• Side-effects associated with X-ray systems
• Complications associated with ablation procedures
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Development of leadless pacemaker
• Increased adoption of multi-functional pacemakers
• Use of mobile ECG monitoring systems
PART 14: Vendor landscape
• Competitive scenario
PART 15: Key vendor analysis
• Boston Scientific
• GE Healthcare
• Medtronic
• Philips Healthcare
• St. Jude Medical
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global EP devices market 2015-2020 ($ billions)
Exhibit 03: Factors impacting the market growth 2015-2020
Exhibit 04: Five forces analysis
Exhibit 05: Global EP devices market 2015-2020
Exhibit 06: Global EP devices market segmentation by product
Exhibit 07: Diagnostic EP devices market 2015-2020 ($billion)
Exhibit 08: X-ray systems market overview
Exhibit 09: X-ray systems market 2015-2020 ($ billion)
Exhibit 10: Factors affecting X-ray systems market 2015-2020
Exhibit 11: Major players in the X-ray systems market
Exhibit 12: ECG devices market overview
Exhibit 13: ECG devices market 2015-2020 ($ billion)
Exhibit 14: Factors affecting ECG devices market 2015-2020
Exhibit 15: Major players in the ECG devices market
Exhibit 16: Diagnostic EP catheters market overview
Exhibit 17: Global diagnostic EP catheters market 2015-2020 ($ billion)
Exhibit 18: Factors affecting diagnostic EP catheters market 2015-2020
Exhibit 19: Major players in the diagnostic EP catheters market
Exhibit 20: Global EMG devices market overview
Exhibit 21: Global EMG devices market 2015-2020 ($ billion)
Exhibit 22: Factors affecting EMG devices market 2015-2020
Exhibit 23: Major players in the EMG devices market
Exhibit 24: Global EEG devices market overview
Exhibit 25: Global EEG devices market 2015-2020 ($ billion)
Exhibit 26: Factors affecting EEG devices market 2015-2020
Exhibit 27: Major players in EEG devices market
Exhibit 28: Global treatment EP devices market 2015-2020 ($ billion)
Exhibit 29: Global ICDs market overview
Exhibit 30: Global ICDs devices market 2015-2020 ($ billion)
Exhibit 31: Factors affecting ICD devices market 2015-2020
Exhibit 32: Major players in the ICD devices market
Exhibit 33: Global cardiac pacemakers market overview
Exhibit 34: Global cardiac pacemakers market 2015-2020 ($ billions)
Exhibit 35: Factor affecting cardiac pacemaker market 2015-2020
Exhibit 36: Major players in the cardiac pacemakers market
Exhibit 37: Global CRT devices market overview
Exhibit 38: Global CRT devices market 2015-2020 ($ billions)
Exhibit 39: Factor affecting CRT devices market 2015-2020
Exhibit 40: Major players in the CRT devices market
Exhibit 41: Global ablation catheters market overview
Exhibit 42: Global ablation catheters market 2015-2020 ($ billion)
Exhibit 43: Factors affecting ablation catheters marker 2015-2020
Exhibit 44: Major players in ablation catheters market
Exhibit 45: Global EP devices market by end-users 2015
Exhibit 46: Total number of diagnostic centers in the US 2008-2013
Exhibit 47: Global EP devices market by geography in 2015 and 2020 ($ billions)
Exhibit 48: Global EP devices market percentage share by geography 2015
Exhibit 49: Americas: Market overview of EP devices
Exhibit 50: EP devices market in Americas 2015-2020 ($ billions)
Exhibit 51: Americas: Market metrics in various countries
Exhibit 52: Key takeaway: EP devices market in US
Exhibit 53: EMEA: Market overview of EP devices
Exhibit 54: EP devices market in EMEA 2015-2020 ($ billions)
Exhibit 55: EMEA: Market metrics in various countries
Exhibit 56: Pacemaker implant centers in major EMEA countries 2014 and 2015
Exhibit 57: Total number of pacemakers implanted in major EMEA countries 2014 and 2015
Exhibit 58: Number of first implants and replacements for pacemaker in 2014
Exhibit 59: Number of first implants and replacements for pacemaker in 2015
Exhibit 60: CRT devices implant centers in EMEA countries 2014 and 2015
Exhibit 61: Total number of CRT devices implanted in major EMEA countries 2014 and 2015
Exhibit 62: ICDs implantation centers in major EMEA countries 2014 and 2015
Exhibit 63: Total number of ICDs implanted in major EMEA countries 2014 and 2015
Exhibit 64: Number of ablation procedures performed in major EMEA countries 2014 and 2015
Exhibit 65: Number of atrial fibrillation ablation procedures in major EMEA countries 2014 and 2015
Exhibit 66: Insurance modality in some EMEA countries 2014
Exhibit 67: Insurance modality in a few EMEA countries 2015
Exhibit 68: APAC: Market overview of EP devices
Exhibit 69: EP devices market in APAC 2015-2020 ($ billions)
Exhibit 70: APAC: Market metrics in various countries
Exhibit 71: Factors affecting the adoption of remote monitoring devices
Exhibit 72: Impact of drivers
Exhibit 73: Side-effects of X-ray systems
Exhibit 74: Impact of drivers and challenges
Exhibit 75: Competitive structure analysis of global EP devices market 2015
Exhibit 76: Strategic success factors of companies in global EP devices market
Exhibit 77: Competitive analysis of global EP devices market 2015
Exhibit 78: Market penetration of various EP device manufacturers 2015
Exhibit 79: Boston Scientific Corporation: Strength analysis
Exhibit 80: Boston Scientific Corporation: Strategy assessment
Exhibit 81: Boston Scientific Corporation: Opportunity assessment
Exhibit 82: GE Healthcare: Strength analysis
Exhibit 83: GE Healthcare: Strategy assessment
Exhibit 84: GE Healthcare: Opportunity assessment
Exhibit 85: Medtronic: Strength analysis
Exhibit 86: Medtronic: Strategy assessment
